News

Nellie Jo Gaston received a lifesaving surgery after an abnormal result from an at-home colon cancer screening test. After treatment at Saint Luke’s, she is cancer-free.

Melissa Magwire, RN, MSN, CDE, discusses the interrelated conditions of diabetes and cardiometabolic disease and how the Cardiometabolic Center of Excellence is changing the game for treatment.

Learn how the Saint Luke’s Michael & Marlys Haverty Cardiometabolic Center of Excellence is making a difference in the lives of diabetes patients.

March is Colorectal Cancer Awareness month, and this week, we are talking with Sabrina Kidd, MD, about colon cancer screenings, treatments, and possible factors contributing to the rise in diagnoses among young adults.

This MS awareness month, Dr. Carolina Garcia, a neurologist at Saint Luke's Comprehensive Multiple Sclerosis Center, discusses diagnosing and treating this inflammatory and presumed autoimmune condition.

Growing research shows why popular GLP-1 weight loss medications might be beneficial for people with multiple sclerosis, but the jury’s still out.

Empower yourself by learning all you can about therapies for multiple sclerosis.

KCTV talked to Melissa Magwire,RN, MSN, CDE, program director of the Saint Luke’s Michael & Marlys Haverty Cardiometabolic Center of Excellence, to learn more about the Cardiometabolic Center.

A recent study out of Harvard School of Public Health found a strong relationship between those who had mononucleosis, or the “kissing disease,” and multiple sclerosis later in life.

An expert with Saint Luke’s Comprehensive Multiple Sclerosis Center discusses early detection and exciting new advances in treatment.